Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. The company develops and commercializes therapeutic products; and cultivates, processes, and sells cannabis products, as well as supplies cannabis retail products. Its products include anibidiol, a complementary feed product for companion animals; cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and zinc that reduces stress and supports psychological and nervous functions; and topical and skin care products, which include cannaDOL, a CBD-based topical gel associated with a mixture of cooling and warming essential oils. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.
The current price of 1X80.F is €7.17 EUR — it has increased by +3.45% in the past 24 hours. Watch Eurobank. stock price performance more closely on the chart.
What is Eurobank. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Eurobank. stocks are traded under the ticker 1X80.F.
What is Eurobank. revenue for the last year?▼
Eurobank. revenue for the last year amounts to 13.26M EUR.
What is Eurobank. net income for the last year?▼
1X80.F net income for the last year is -32.17M EUR.
In which sector is Eurobank. located?▼
Eurobank. operates in the Technology sector.
When did Eurobank. complete a stock split?▼
The last stock split for Eurobank. was on June 04, 2024 with a ratio of 1:30.